Enterome
Paris, France · Science and Engineering
Do your work at Enterome?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Nov 2025
Enterome is a Science and Engineering company based in Paris, France, founded in 2011, with 50-100 employees. Enterome's profile is verified on Enterprise League.
Overview
We are a clinical stage biopharmaceutical company developing developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases.
We have developed two highly promising pipelines of clinical and pre-clinical candidates with a focus on cancer and auto-immune diseases:
- OncoMimics™: highly effective, off-the-shelf therapeutic vaccines against cancers (EO2401, EO2463). EO2401 is in Phase 1/2 clinical trials in patients with glioblastoma and adrenal tumors. EO2463 is in a Phase 1/2 clinical trial for indolent non-Hodgkin B-cell lymphomas.
- EndoMimics™: a pipeline of next generation bioactives acting like human hormones or cytokines for the treatment of immune diseases. EB1010, the lead candidate, is a potent local inducer of IL-10 designed to provide improved therapeutic outcomes for patients with IBD.
In addition, Enterome’s clinical candidate sibofimloc (also referred to as TAK-018) is advancing through a Phase 2 clinical trial in post-operative Crohn’s disease. Sibofimloc has been partnered with Takeda globally, with Enterome retaining a significant profit share in the US.
Contact Details
info@enterome.com
Paris, France
Founded
2011
Employees
50-100
Categories
Keywords
#Immuno-oncology
#Auto-immunity
#Inflammatory Bowel Diseases
#Microbiome
#Metagenomics
#Immunotherapies
Companies teams usually look at after Enterome
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.